Foto del docente

Anna Rita Franco Migliaccio

Professoressa ordinaria

Dipartimento di Scienze Biomediche e Neuromotorie

Settore scientifico disciplinare: BIO/17 ISTOLOGIA

Temi di ricerca

Parole chiave: cellula staminale emopoietica eritropoiesi medicina trasfusionale terapia cellulare e rigenerativa fattori di trascrizione fattori di crescita neoplasie mieloproliferative megacariocitopoiesi e piastrine

  • 2018 - 2023

2P01CA108671-10A1 (Hoffman)

Titolo: MPN Research Consortium – Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis

  • The scope of this project is to exploit the Gata1low mouse model to detail the pathobiological pathway leading to development of increased stem/progenitor cell trafficking and extramedullary hematopoiesis in myleofibrosis
  • 5R01HL134684-02

Titolo: Generation of cultured RBCs with rare phenotypes for transfusion from sources usually discarded during regular blood donation

  • 2020-2025

AIRC IG23525

Titolo: Contributions of cytokines to the etiology and progression of primary myelofibrosis

  • III2017AIRCIG17608MIGLIACCIO

Title: Dissecting the role of TGF-beta in the pathogenesis of primary myelofibrosis

  • 2007-2010

New York State Star Program: "Personalized Therapies for Sickle Cell Disease and Thalassemia."

The scope of this project is to develop in vitro assays to predict the response to therapy with histone deacetylase inhibitors of sickle cell and thalassemia patients.

  • 2006-2010

P01-CA108671-04 "Mouse models of Myelofibrosis"

Titolo: MPN Research Consortium – Project 2: Defining the role of megakaryocyte abnormalities in the progression of primary myelofibrosis

The scope of this project is to exploit the Gata1low mouse model to detail the pathobiological pathway leading to development of increased stem/progenitor cell trafficking and extramedullary hematopoiesis in myleofibrosis

  • 2004-2009
Member of the Program for Excellency in Training "Eurythron" European Community The scope of this project is to establish a multicenter excellence training program in Experimental Hematology

Ultimi avvisi

Al momento non sono presenti avvisi.